212 related articles for article (PubMed ID: 31008931)
1. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q
Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
[TBL] [Abstract][Full Text] [Related]
5. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Chaib I; Karachaliou N; Pilotto S; Codony Servat J; Cai X; Li X; Drozdowskyj A; Servat CC; Yang J; Hu C; Cardona AF; Vivanco GL; Vergnenegre A; Sanchez JM; Provencio M; de Marinis F; Passaro A; Carcereny E; Reguart N; Campelo CG; Teixido C; Sperduti I; Rodriguez S; Lazzari C; Verlicchi A; de Aguirre I; Queralt C; Wei J; Estrada R; Puig de la Bellacasa R; Ramirez JL; Jacobson K; Ditzel HJ; Santarpia M; Viteri S; Molina MA; Zhou C; Cao P; Ma PC; Bivona TG; Rosell R
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376152
[TBL] [Abstract][Full Text] [Related]
6. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
Li N; Zheng X; Gan J; Zhuo T; Li X; Yang C; Wu Y; Qin S
Chin Med J (Engl); 2023 Nov; 136(21):2562-2572. PubMed ID: 37925595
[TBL] [Abstract][Full Text] [Related]
8. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.
Zhang L; Song X; Li X; Wu C; Jiang J
Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis.
Ma H; Tian X; Zeng XT; Zhang Y; Wang Y; Wang F; Zhou JG
Medicine (Baltimore); 2016 Jan; 95(2):e2495. PubMed ID: 26765461
[TBL] [Abstract][Full Text] [Related]
10. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
[TBL] [Abstract][Full Text] [Related]
11. EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis.
Phan TT; Tran VT; Tran BT; Ho TT; Pho SP; Le AT; Le VT; Nguyen HT; Nguyen ST
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1544. PubMed ID: 34427045
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of YAP1 on clinical outcomes in human cancers.
Wu Y; Hou Y; Xu P; Deng Y; Liu K; Wang M; Tian T; Dai C; Li N; Hao Q; Song D; Zhou LH; Dai Z
Aging (Albany NY); 2019 Oct; 11(19):8681-8700. PubMed ID: 31613226
[TBL] [Abstract][Full Text] [Related]
13. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis.
Zhang H; Yin M; Hu Y; Jiang M; Lu M; Wu Y
Rev Esp Enferm Dig; 2024 Mar; 116(3):148-156. PubMed ID: 36177818
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.
Cheng H; Zhang Z; Rodriguez-Barrueco R; Borczuk A; Liu H; Yu J; Silva JM; Cheng SK; Perez-Soler R; Halmos B
Oncotarget; 2016 May; 7(20):28976-88. PubMed ID: 26716514
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Fan G; Zhang K; Ding J; Li J
Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
[TBL] [Abstract][Full Text] [Related]
19. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the impact of de novo and acquired
Liu Y; Sun L; Xiong ZC; Sun X; Zhang SL; Ma JT; Han CB
Onco Targets Ther; 2017; 10():2267-2279. PubMed ID: 28479857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
